Gary Glandon

Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma

Energy Conversion Devices, Inc. engages in the design, manufacture and sale of photovoltaic products. It manufactures and sells thin-film solar laminates that convert sunlight to energy using proprietary technology. Energy Conversion Devices operates in two reportable business segments, namely, United Solar Ovonic and Ovonic Materials. The United Solar Ovonic segment designs, manufactures and sells PV laminates that generate clean, renewable energy by converting sunlight into electricity. The Ovonic Materials segment invents, designs and develops materials and products based on its pioneering materials science technology. Energy Conversion Devices also designs, manufactures and installs rooftop photovoltaic systems, which enable customers to transform unused space on the rooftop into a value-generating asset. The company was founded in 1960 and is headquartered in Rochester Hills, MI.

Solutia, Inc. manufactures performance materials and specialty chemicals. The company was founded in April 1997 and is headquartered in St. Louis, MO.

Honeywell Aerospace provides integrated avionics, engines, systems and services for aircraft manufacturers. The firm's products include avionics and electronics, air transport systems, business and general aviation systems, defense electronics, fasteners and hardware, bearings, electrical and electromechanical components, seals, pneumatic systems and components, hydraulic systems, integrated environmental control systems, wheel and brake products, auxiliary power units, ground power units, propulsion engines, space systems and services and microelectronics. The company was founded in 1985 and is headquartered in Phoenix, AZ.